Pain Management After Cesarean Delivery Among Women with Opioid Use Disorder: Results from a Retrospective Pregnancy Cohort in a Rural Region of the Midwest

Background: Increasing numbers of pregnant women are being treated with buprenorphine for opioid use disorder (OUD), which can interfere with effectiveness of other opioids used for pain relief, making perioperative guidance for patients requiring cesarean delivery unclear. Methods: Using a retrospective cohort design, we abstracted 8 years of medical records (2013–2020) from a hospital in rural Michigan. We compared analgesic use (as a proxy for pain) and hospital length of stay (LOS) between groups of women with OUD whose buprenorphine treatment was (1) discontinued before cesarean delivery (discontinuation) versus (2) continued throughout the perioperative period (maintenance). We used t-tests and Fisher's Exact tests for comparison of continuous and categorical variables, respectively. Results: Maternal characteristics reflected the local population (87% non-Hispanic White; 9% American Indian). Of 12,179 mothers giving birth during the study timeframe, 87 met all inclusion criteria (2.4% with diagnosed OUD; 38% of those delivered by cesarean; 76% of those received prenatal buprenorphine treatment). Using the first 2 days of the hospital stay as the standard time window for comparison, there were no differences in perioperative opioid analgesic use (mean ± standard deviation [SD] = 141.6 ± 205.4 vs. 134.0 ± 136.3 morphine milligram equivalents, p = 0.89) or LOS (mean ± SD = 2.9 ± 0.9 vs. 3.3 ± 1.0 days, p = 0.14) between discontinuation (n = 17) versus maintenance (n = 70). There was a lower use of acetaminophen in the discontinuation group (mean ± SD = 3,842.6 ± 2,108.1 vs. 4,938.2 ± 2,008.4 mg, p = 0.0489). Conclusion: This study provides empirical evidence supporting continued buprenorphine treatment for women with OUD throughout the perioperative period of a cesarean delivery in a rural setting, although replication with larger sample sizes would provide more confidence in the results.

[1]  R. Warters,et al.  A Retrospective Study of Acute Postoperative Pain After Cesarean Delivery in Patients With Opioid Use Disorder Treated With Opioid Agonist Pharmacotherapy , 2022, Journal of addiction medicine.

[2]  Joel Smith,et al.  Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section , 2022, Substance abuse : research and treatment.

[3]  E. Fry Buprenorphine , 2021, Reactions Weekly.

[4]  T. Wilens,et al.  Methadone and Buprenorphine Discontinuation among Postpartum Women with Opioid Use Disorder. , 2021, American journal of obstetrics and gynecology.

[5]  M. Kariisa,et al.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019 , 2021, MMWR. Morbidity and mortality weekly report.

[6]  R. Joe Methadone , 2020, Reactions Weekly.

[7]  R. Landau,et al.  Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery. , 2019, International journal of obstetric anesthesia.

[8]  M. Werler,et al.  Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects. , 2019, Clinical therapeutics.

[9]  A. Quaye,et al.  Perioperative Management of Buprenorphine: Solving the Conundrum. , 2018, Pain medicine.

[10]  W. Callaghan,et al.  Opioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014 , 2018, MMWR. Morbidity and mortality weekly report.

[11]  T. Wilens,et al.  Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts. , 2018, Obstetrics and gynecology.

[12]  T. Wilens,et al.  Opioid Use Disorders: Perioperative Management of a Special Population , 2018, Anesthesia and analgesia.

[13]  D. Alford,et al.  Comparison of Post-Cesarean Section Opioid Analgesic Requirements in Women With Opioid Use Disorder Treated With Methadone or Buprenorphine , 2017, Journal of addiction medicine.

[14]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[15]  H. Jones,et al.  Management of Acute Postpartum Pain in Patients Maintained on Methadone or Buprenorphine During Pregnancy , 2009, The American journal of drug and alcohol abuse.

[16]  D. Alford,et al.  Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy , 2006, Annals of Internal Medicine.

[17]  Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. , 2017, Obstetrics and gynecology.